Lanean...
The Emerging Science of Precision Medicine and Pharmacogenomics for Parkinson’s Disease
Current therapies for Parkinson’s disease are problematic because they are symptomatic and have adverse effects. New drugs have failed in clinical trials due to inadequate efficacy. At the core of the problem is trying to make one drug work for all Parkinson’s disease patients, when we know this pre...
Gorde:
| Argitaratua izan da: | Mov Disord |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5570630/ https://ncbi.nlm.nih.gov/pubmed/28686320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.27099 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|